FDA daily for Sunday, August 16, 2026
In this issue: 1 approval and 6 label changes. 2 items touch categories MedGrid carries, and they come first.
For MedGrid's categories
Items in this issue that name a product category sold on MedGrid. Each links to its full FDA record; the chip opens that category's federal and state rules.
- JOHNSON FOAM
MINOXIDIL · JOHNSON BIOPHARMACEUTICAL INC. · TOPICAL
- JOHNSON FOAM PRO
FINASTERIDE FOAM WITH 5% MINOXIDIL · JOHNSON BIOPHARMACEUTICAL INC. · TOPICAL
Drug and biologic approvals
FDA date:On Sun, Aug 9 FDA approved 1 new application (1 brand or biologic, 0 generic) and no supplements to existing ones.
- NITROUS OXIDE, USP
LINDE GAS EQUIP · NITROUS OXIDE
Label updates
FDA date:6 drug labels took effect on Sun, Aug 2; 3 are for products in MedGrid's categories. Below: those, and labels carrying a boxed warning.
- JOHNSON FOAM
MINOXIDIL · JOHNSON BIOPHARMACEUTICAL INC. · TOPICAL
- JOHNSON FOAM PRO
FINASTERIDE FOAM WITH 5% MINOXIDIL · JOHNSON BIOPHARMACEUTICAL INC. · TOPICAL
- LYOPHILIZED AMNION WITH ALBUMIN
HUMAN AMNIOTIC MEMBRANE · Guangzhou Yilong Cosmetics.,Ltd · TOPICAL
How the FDA daily is written
Every issue is written from FDA's public data (openFDA) and nothing else: the counts, names, firms and reasons are FDA's own. openFDA posts each kind of record on its own delay, so each section covers one FDA date and says which. Shortages cover yesterday; approvals, drug and device recalls, and food and supplement recalls cover a week ago; device clearances and label changes cover two weeks ago. Every FDA date appears in exactly one issue. Complete response letters appear the day after FDA publishes a batch.
Subscribe with any feed reader, or point an email tool at the RSS feed to send each issue as a newsletter. Search any drug, device or company across every FDA dataset in the FDA data explorer.
